Trailing-twelve-month (TTM) revenue is $1.27 Billion with a year-over-year growth of +25.29%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $307,792,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $319,688,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $327,267,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-30 | $313,422,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $1,268,169,000 |
Current P/S: $344,639,100 market capitalization ÷ $1,268,169,000 TTM revenue = 0.27x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $313.42M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:58:29.503Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Other Products And Services | $2M | $663,000 | $427,000 | $199,000 | $199,000 | $310,000 |
$1.27B
$1.27 Billion
+25.29%
vs. $1.01B a year ago (TTM)
+5.18%
5 Year compound annual growth rate
1 Year
+25.29%
3 Year
+15.51%
5 Year
+5.18%
10 Year
+14.17%
15 Year
+18.67%
20 Year
+14.59%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.12B | +$217.10M | +24.12% |
| 2024 | $900.22M | +$227.72M | +33.86% |
| 2023 | $672.50M | ($312.49M) | (31.73%) |
| 2022 | $984.99M | ($113.51M) | (10.33%) |
| 2021 | $1.10B | +$188.51M | +20.72% |
| 2020 |
TTM Growth
+25.29%
3-Year CAGR
+15.51%
5-Year CAGR
+5.18%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $909.99M |
| ($196.61M) |
| (17.77%) |
| 2019 | $1.11B | +$341.74M | +44.68% |
| 2018 | $764.87M | +$147.13M | +23.82% |
| 2017 | $617.74M | +$233.33M | +60.70% |
| 2016 | $384.40M | +$130.19M | +51.21% |
